GAD2 on chromosome 10p12 is a candidate gene for human obesity

被引:116
作者
Boutin, P
Dina, C
Vasseur, F
Dubois, S
Corset, L
Séron, K
Bekris, L
Cabellon, J
Neve, B
Vasseur-Delannoy, V
Chikri, M
Charles, MA
Clement, K
Lernmark, A
Froguel, P [1 ]
机构
[1] Inst Pasteur, CNRS, Inst Biol, F-59019 Lille, France
[2] Univ Hosp Lille, Lille, France
[3] Univ Washington, Dept Med, Seattle, WA 98195 USA
[4] Hop Paul Brousse, INSERM, Villejuif, France
[5] Univ Paris 06, Paris, France
[6] Hop Hotel Dieu, INSERM Avenir, Dept Nutr, F-75181 Paris, France
[7] Univ London Imperial Coll Sci Technol & Med, Hammersmith Genome Ctr, London, England
[8] Univ London Imperial Coll Sci Technol & Med, Dept Genomic Med, London, England
基金
英国医学研究理事会;
关键词
D O I
10.1371/journal.pbio.0000068
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The gene GAD2 encoding the glutamic acid decarboxylase enzyme (GAD65) is a positional candidate gene for obesity on Chromosome 10p11-12, a susceptibility locus for morbid obesity in four independent ethnic populations. GAD65 catalyzes the formation of gamma-aminobutyric acid (GABA), which interacts with neuropeptide Y in the paraventricular nucleus to contribute to stimulate food intake. A case-control study (575 morbidly obese and 646 control subjects) analyzing GAD2 variants identified both a protective haplotype, including the most frequent alleles of single nucleotide polymorphisms (SNPs) +61450 C>A and +83897 T>A (OR = 0.81, 95% Cl [0.681-0.972], p = 0.0049) and an at-risk SNP (-243 A>G) for morbid obesity (OR = 1.3, 05% Cl [1.053-1.5851, p = 0.014]). Furthermore, familial-based analyses confirmed the association with the obesity of SNP +61450 C>A and +83897 T>A haplotype (chi(2) = 7.637, p = 0.02). In the murine insulinoma cell line betaTC3, the G at-risk allele of SNP -243 A>G increased six times GAD2 promoter activity (p < 0.0001) and induced a 6-fold higher affinity for nuclear extracts. The -243 A>G SNP was associated with higher hunger scores (p = 0.007) and disinhibition scores (p = 0.028), as assessed by the Stunkard Three-Factor Eating Questionnaire. As GAD2 is highly expressed in pancreatic beta-cells, we analyzed GAD65 antibody level as a marker of beta-cell activity and of insulin secretion. In the control group, -243 A>G, +61450 C>A, and +83897 T>A SNPs were associated with lower GAD65 autoantibody levels (p values of 0.003, 0.047, and 0.006, respectively). SNP +83897 T>A was associated with lower fasting insulin and insulin secretion, as assessed by the HOMA-B% homeostasis model of beta-cell function (p = 0.009 and 0.01, respectively). These data support the hypothesis of the orexigenic effect of GABA in humans and of a contribution of genes involved in GABA metabolism in the modulation of food intake and in the development of morbid obesity.
引用
收藏
页码:361 / 371
页数:11
相关论文
共 53 条
[1]   Patterns of linkage disequilibrium in the human genome [J].
Ardlie, KG ;
Kruglyak, L ;
Seielstad, M .
NATURE REVIEWS GENETICS, 2002, 3 (04) :299-309
[2]  
ARDLIE KG, 2002, AM J HUM GENET, V71, P1478
[3]   Effect of injection of antisense oligodeoxynucleotides of GAD isozymes into rat ventromedial hypothalamus on food intake and locomotor activity [J].
Bannai, M ;
Ichikawa, M ;
Nishihara, M ;
Takahashi, M .
BRAIN RESEARCH, 1998, 784 (1-2) :305-315
[4]   Gut hormone PYY3-36 physiologically inhibits food intake [J].
Batterham, RL ;
Cowley, MA ;
Small, CJ ;
Herzog, H ;
Cohen, MA ;
Dakin, CL ;
Wren, AM ;
Brynes, AE ;
Low, MJ ;
Ghatei, MA ;
Cone, RD ;
Bloom, SR .
NATURE, 2002, 418 (6898) :650-654
[5]   Identification of N-acetyltransferase 2 genotypes by continuous monitoring of fluorogenic hybridization probes [J].
Blömeke, B ;
Sieben, S ;
Spötter, D ;
Landt, O ;
Merk, HF .
ANALYTICAL BIOCHEMISTRY, 1999, 275 (01) :93-97
[6]   Binge eating as a major phenotype of melanocortin 4 receptor gene mutations [J].
Branson, R ;
Potoczna, N ;
Kral, JG ;
Lentes, K ;
Hoehe, MR ;
Horber, FF .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (12) :1096-1103
[7]   Significant linkage on chromosome 10p in families with bulimia nervosa [J].
Bulik, CM ;
Devlin, B ;
Bacanu, SA ;
Thornton, L ;
Klump, KL ;
Fichter, MM ;
Halmi, KA ;
Kaplan, AS ;
Strober, M ;
Woodside, DB ;
Bergen, AW ;
Ganjei, JK ;
Crow, S ;
Mitchell, J ;
Rotondo, A ;
Mauri, M ;
Cassano, G ;
Keel, P ;
Berrettini, WH ;
Kaye, WH .
AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (01) :200-207
[8]   The human obesity gene map:: The 2002 update [J].
Chagnon, YC ;
Rankinen, T ;
Snyder, EE ;
Weisnagel, SJ ;
Pérusse, LK ;
Bouchard, C .
OBESITY RESEARCH, 2003, 11 (03) :313-367
[9]  
Charles MA, 2002, ANN ENDOCRINOL-PARIS, V63, P154
[10]  
Clement Karine, 2002, Am J Pharmacogenomics, V2, P177, DOI 10.2165/00129785-200202030-00003